Ambrx Biopharma (AMAM) - 2021 Q4 - Earnings Call Transcript

Call Start: 16:30 January 1, 0000 5:06 PM ET Ambrx Biopharma Inc. (NASDAQ:AMAM) Q4 2021 Earnings Conference Call April 26, 2022, 4:30 PM ET Company Participants Feng Tian – Chief Executive Officer Sonja Nelson – Chief Financial Officer Laurence Watts – Managing Director, Gilmartin Group Conference Call Participants Corinne Jenkins – Goldman Sachs Tazeen Ahmad – Bank of America Phil Nadeau – Cowen & Co. Joel Beatty – Baird Operator Welcome to the Ambrx Second Half and Full Year 2021 Financial Results and Co ...